ArticleClinical breast cancer2024

A Phase I Trial of Alpelisib Combined With Capecitabine in Patients With HER2-Negative Metastatic Breast Cancer.

Danielle M File et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.